Monthly Archives: November 2014

//November
28 11, 2014

Beckman Coulter Diagnostics and Seegene Ink Molecular Diagnostic Assay Supply Agreement

By |November 28th, 2014|Beckman Coulter, Molecular Diagnostics|Comments Off on Beckman Coulter Diagnostics and Seegene Ink Molecular Diagnostic Assay Supply Agreement

Beckman Coulter Diagnostics and Seegene Inc. have signed a Molecular Diagnostic assay supply agreement according to which Seegene will manufacture and supply reagents for Beckman Coulter's VERIS MDx System, a new sample-to-answer molecular diagnostics instrument. Seegene Inc., a leading developer of multiplex PCR technologies, is dedicated to developing new technology for accurate diagnosis. Beckman Coulter [...]

27 11, 2014

Roche Cobas HPV Test – An Efficient Option for Primary Cervical Cancer Screening

By |November 27th, 2014|Cervical Cancer, Roche Diagnostics|Comments Off on Roche Cobas HPV Test – An Efficient Option for Primary Cervical Cancer Screening

According to the American Cancer Society, cervical cancer is one of the most successfully treatable cancers if detected early. Cervical cancer can sometimes be found early and even prevented entirely by having regular Pap tests, which examine cervical cells for changes indicative of cervical cancer. However, studies show that Pap cytology can have high false-negative [...]

26 11, 2014

Beckman Coulter’s Flow Cytometry Expertise for ONE Study

By |November 26th, 2014|Beckman Coulter, Flow Cytometers|Comments Off on Beckman Coulter’s Flow Cytometry Expertise for ONE Study

Beckman Coulter Life Sciences is participating in ONE Study, a global cooperative project which applies the innovative concept of cell therapy to human clinical organ transplantation. A leading manufacturer of sophisticated instrument systems, reagents and services for research and clinical applications, Beckman Coulter is contributing its flow cytometry expertise in cell therapy and diagnostic technologies [...]

25 11, 2014

Study Assesses Safety Considerations in the Lab Testing of Ebola Virus Specimens

By |November 25th, 2014|Ebola, Laboratory Equipment|Comments Off on Study Assesses Safety Considerations in the Lab Testing of Ebola Virus Specimens

Countries all over the world now recognize the Ebola virus disease as a threat. The United States is helping to fight the spread of the disease in West Africa and also providing care for those infected, including patients brought to the United States for treatment. The federal government has asked clinical laboratories to take stock [...]

24 11, 2014

Transparency in Healthcare Pricing Can Reduce HealthCare Costs

By |November 24th, 2014|Healthcare, Laboratory Tests|Comments Off on Transparency in Healthcare Pricing Can Reduce HealthCare Costs

The call for healthcare pricing transparency is growing stronger as the nation struggles to control rising healthcare costs. A new study published in JAMA reports that patient awareness about pricing related to services before they were used resulted in lower claims payments for 3 common medical services - diagnostic laboratory tests, advanced imaging services, and [...]

21 11, 2014

Beckman Coulter Launches Next Gen HbA1c Test for All Clinical UniCel DxC and AU Chemistry Systems

By |November 21st, 2014|Beckman Coulter, Chemistry Analyzers|Comments Off on Beckman Coulter Launches Next Gen HbA1c Test for All Clinical UniCel DxC and AU Chemistry Systems

Beckman Coulter is a trusted partner in clinical diagnostics, offering a wide range of innovative diagnostic instruments, tests and information systems to help labs improve productivity, processes and performance. The company recently launched a next generation Hemoglobin A1c (HbA1c) assay with improved performance for its UniCel DxC and AU chemistry analyzers. The new test can [...]

20 11, 2014

Preventing Errors in hCG POC Reporting

By |November 20th, 2014|Laboratory Equipment, Point of Care Testing|Comments Off on Preventing Errors in hCG POC Reporting

Measurement of hCG (human chorionic gonadotropin) in blood or urine is used mainly in the determination of pregnancy. In a healthcare setting, urine samples are the preferred choice and they are tested for hCG using a qualitative point-of-care (POC) device. Urine hCG POC tests generally have low false-negative rates. However, sometimes qualitative hCG tests may [...]

19 11, 2014

Advantages of Automated Hematology Analyzers

By |November 19th, 2014|Hematology Analyzers|Comments Off on Advantages of Automated Hematology Analyzers

The importance of automation in hematology hardly needs to be stressed. Modern automated hematology systems are designed to meet the needs of high volume laboratories. They can measure several analytical parameters such as White Blood Cell (WBC) or leukocyte count, lymphocyte percent and number, mononuclear cell percent and number, granulocyte percent and number, Red Blood [...]

18 11, 2014

Siemens Joins Team to Build the Lab of the Future

By |November 18th, 2014|DNA Analyzer, Siemens Healthcare|Comments Off on Siemens Joins Team to Build the Lab of the Future

Siemens recently announced that it has joined forces with industry leader Inpeco to build a customized 'lab of the future' for Quest Diagnostics in Marlborough, MA. According to the terms of this exclusive contract, Siemens Healthcare and Inpeco will be responsible for automating the new clinical laboratory which will be the first comprehensive automation solution [...]

17 11, 2014

The Real Time RT-PCR (TaqMan®) Assay

By |November 17th, 2014|Benchmark Scientific, Ebola|Comments Off on The Real Time RT-PCR (TaqMan®) Assay

The FDA authorizes the use of the Ebola virus (Zaire) Real Time RT-PCR (TaqMan®) assay or the EZ1 assay if infection with Ebola Zaire virus (detected in the West Africa outbreak in 2014) is suspected based on clinical and epidemiological screening criteria. The EZ1 assay allows the in vitro qualitative detection of viral RNA isolated [...]